Roberto Cauda
Researcher Next ID · RN-019430
Researcher · Immunology and Microbiology
Università Cattolica del Sacro Cuore
Milan, Philippines
- Works count
- 553
- Citation count
- 21,076
- H-index
- 67
- i10-index
- 312
Research interests
Publications
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study
Clinical Infectious Diseases · 2021 · 10.1093/cid/ciab176
Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy
Journal of Infection · 2020 · 10.1016/j.jinf.2020.03.058
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study
Nutrition Metabolism and Cardiovascular Diseases · 2020 · https://doi.org/10.1016/j.numecd.2020.07.031
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused byKlebsiella pneumoniaeCarbapenemase–producingK. pneumoniae
Clinical Infectious Diseases · 2018 · 10.1093/cid/ciy492
Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study
Journal of Antimicrobial Chemotherapy · 2015 · 10.1093/jac/dkv086
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
Clinical Microbiology and Infection · 2015 · 10.1016/j.cmi.2015.08.001
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study
Clinical Microbiology and Infection · 2014 · 10.1111/1469-0691.12747
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Clinical Infectious Diseases · 2012 · https://doi.org/10.1093/cid/cis588
Risk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital
PLoS ONE · 2012 · 10.1371/journal.pone.0033705
Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System
Antimicrobial Agents and Chemotherapy · 2011 · 10.1128/aac.00009-11
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
Neurology · 2011 · 10.1212/wnl.0b013e31821670fb
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy
Antimicrobial Agents and Chemotherapy · 2010 · https://doi.org/10.1128/aac.00143-10
Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
Journal of Infection · 2009 · https://doi.org/10.1016/j.jinf.2009.02.002
Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment
Antimicrobial Agents and Chemotherapy · 2007 · 10.1128/aac.01509-06
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy · 2007 · 10.1093/jac/dkm416
Biofilm Production by Candida Species and Inadequate Antifungal Therapy as Predictors of Mortality for Patients with Candidemia
Journal of Clinical Microbiology · 2007 · 10.1128/jcm.00131-07
Benefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital Stay
The American Journal of Medicine · 2006 · https://doi.org/10.1016/j.amjmed.2006.03.034
New insights into the antiviral effects of chloroquine
The Lancet Infectious Diseases · 2006 · 10.1016/s1473-3099(06)70361-9
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial
Journal of Antimicrobial Chemotherapy · 2006 · https://doi.org/10.1093/jac/dkl372
Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical Outcome
Antimicrobial Agents and Chemotherapy · 2006 · 10.1128/aac.50.2.498-504.2006
Effects of chloroquine on viral infections: an old drug against today's diseases
The Lancet Infectious Diseases · 2003 · https://doi.org/10.1016/s1473-3099(03)00806-5
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)
AIDS · 2002 · https://doi.org/10.1097/00002030-200202150-00008
Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy
AIDS · 2001 · https://doi.org/10.1097/00002030-200108170-00005
In Vitro and In Vivo Anticandidal Activity of Human Immunodeficiency Virus Protease Inhibitors
The Journal of Infectious Diseases · 1999 · https://doi.org/10.1086/314871
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
The Journal of Immunology · 1996 · 10.4049/jimmunol.157.3.1271
Current projects
No projects listed.